Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term pathology. Found 673 abstracts

no pagination
Cohen EE, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet (London, England). 2019 Jan 12;393(10167):156-67.
Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algul H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. The New England journal of medicine. 2019 Jul 25;381(4):317-27.   PMCID: PMC6810605
Hamy AS, Tury S, Wang X, Gao J, Pierga JY, Giacchetti S, Brain E, Pistilli B, Marty M, Espie M, Benchimol G, Laas E, Lae M, Asselain B, Aouchiche B, Edelman M, Reyal F. Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial. J Clin Oncol. 2019 Mar 10;37(8):624-35.   PMCID: PMC6804843
Jones CE, Hammer AM, Cho Y, Sizemore GM, Cukierman E, Yee LD, Ghadiali SN, Ostrowski MC, Leight JL. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia (New York, NY). 2019 Jan;21(1):132-45.   PMCID: PMC6293034
Necchi A, Mariani L, Lo Vullo S, Yu EY, Woods ME, Wong YN, Harshman LC, Alva A, Sternberg CN, Bamias A, Grivas P, Koshkin VS, Roghmann F, Dobruch J, Eigl BJ, Nappi L, Milowsky MI, Niegisch G, Pal SK, De Giorgi U, Recine F, Vaishampayan U, Berthold DD, Bowles DW, Baniel J, Theodore C, Ladoire S, Srinivas S, Agarwal N, Crabb S, Sridhar S, Golshayan AR, Ohlmann C, Xylinas E, Powles T, Rosenberg JE, Bellmunt J, van Rhijn B, Galsky MD, Hendricksen K. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis. European urology focus. 2019 Mar;5(2):242-9.   PMCID: PMC5712487
Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM. Update on perioperative systemic therapy for urothelial carcinoma. Clinical advances in hematology & oncology : H&O. 2019 Mar;17(3):176-83.
Santerre M, Chatila W, Wang Y, Mukerjee R, Sawaya BE. HIV-1 Nef promotes cell proliferation and microRNA dysregulation in lung cells. Cell cycle (Georgetown, Tex). 2019 Jan;18(2):130-42.
Zamanova S, Shabana AM, Mondal UK, Ilies MA. Carbonic anhydrases as disease markers. Expert opinion on therapeutic patents. 2019 Jul;29(7):1-25.   PMCID: PMC6612586
Ablain J, Xu M, Rothschild H, Jordan RC, Mito JK, Daniels BH, Bell CF, Joseph NM, Wu H, Bastian BC, Zon LI, Yeh I. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science (New York, NY). 2018 Nov 30;362(6418):1055-60.   PMCID: PMC6475924
Amin A, Plimack ER, Ernstoff MS, Lewis LD, Bauer TM, McDermott DF, Carducci M, Kollmannsberger C, Rini BI, Heng DY, Knox J, Voss MH, Spratlin J, Berghorn E, Yang L, Hammers HJ. Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Journal for immunotherapy of cancer. 2018 Oct 22;6(1):109.   PMCID: PMC6196426
Arosarena OA, Barr EW, Thorpe R, Yankey H, Tarr JT, Safadi FF. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases. Journal of cellular physiology. 2018 Jan;233(1):409-21.   PMCID: PMC5592128
Chang WL, Jackson C, Riel S, Cooper HS, Devarajan K, Hensley HH, Zhou Y, Vanderveer LA, Nguyen MT, Clapper ML. Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas. Gut. 2018 Jul;67(7):1290-8.   PMCID: PMC6031273
Chhatre S, Jefferson A, Cook R, Meeker CR, Kim JH, Hartz KM, Wong YN, Caruso A, Newman DK, Morales KH, Jayadevappa R. Patient-centered recruitment and retention for a randomized controlled study. Trials. 2018 Mar 27;19(1):205.   PMCID: PMC5870194
Fatkhullina AR, Peshkova IO, Dzutsev A, Aghayev T, McCulloch JA, Thovarai V, Badger JH, Vats R, Sundd P, Tang HY, Kossenkov AV, Hazen SL, Trinchieri G, Grivennikov SI, Koltsova EK. An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis. Immunity. 2018 Nov 20;49(5):943-957e9.   PMCID: PMC6257980
Gerson JN, Ramamurthy C, Borghaei H. Managing adverse effects of immunotherapy. Clinical advances in hematology & oncology : H&O. 2018 May;16(5):364-74.   PMCID: Review
Gettinger S, Hellmann MD, Chow LQ, Borghaei H, Antonia S, Brahmer JR, Goldman JW, Gerber DE, Juergens RA, Shepherd FA, Laurie SA, Young TC, Li X, Geese WJ, Rizvi N. Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC. J Thorac Oncol. 2018 Sep;13(9):1363-72.
Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. Clinical advances in hematology & oncology : H&O. 2018 Oct;16(10):677-86.
Gomez K, Miura S, Huuki LA, Spell BS, Townsend JP, Kumar S. Somatic evolutionary timings of driver mutations. BMC cancer. 2018 Jan 18;18(1):85.   PMCID: PMC5774140
Hahn NM, Necchi A, Loriot Y, Powles T, Plimack ER, Sonpavde G, Roupret M, Kamat AM. Role of Checkpoint Inhibition in Localized Bladder Cancer. European urology oncology. 2018 Aug;1(3):190-8.
Haifler M, Pence I, Sun Y, Kutikov A, Uzzo RG, Mahadevan-Jansen A, Patil CA. Discrimination of malignant and normal kidney tissue with short wave infrared dispersive Raman spectroscopy. Journal of biophotonics. 2018 Jun;11(6):e201700188.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term pathology

pathology drug therapy therapeutic use genetics metabolism Middle Aged Male Aged Female adverse effects Antineoplastic Agents Adult methods Neoplasm Metastasis Neoplastic Gene Expression Regulation Signal Transduction antagonists & inhibitors Antineoplastic Combined Chemotherapy Protocols Mice Kidney Neoplasms Progression-Free Survival Tumor Cell Line secondary Disease Progression enzymology physiology Urinary Bladder Neoplasms etiology pharmacology Head and Neck Neoplasms mortality CTLA-4 Antigen Cell Survival Non-Small-Cell Lung Carcinoma Neoplasm Invasiveness Retrospective Studies Phase II Clinical Trials as Topic administration & dosage B7-H1 Antigen Kaplan-Meier Estimate prevention & control Programmed Cell Death 1 Receptor immunology Cell Movement Transfection 80 and over Aged Lung Neoplasms Monoclonal Antibodies Transitional Cell Carcinoma Randomized Controlled Trials as Topic Adjuvant Chemotherapy Neoadjuvant Therapy therapy Renal Cell Carcinoma Treatment Outcome Nivolumab Monoclonal Antibodies-Humanized Collagen Proto-Oncogene Proteins c-kit Gene Expression Mitochondria Membrane Glycoproteins Gene Knockdown Techniques Neoplasms Human immunodeficiency virus (HIV) human psychology extracellular matrix Clonal Evolution HIV Infections Enzymologic Gene Expression Regulation virology RNA Interference matrix metalloproteinases Therapy Colorectal Neoplasms Pyrimidines Tyrosine kinase inhibitor MicroRNAs Cyclooxygenase 2 Inhibitors Squamous Cell Carcinoma of Head and Neck Hepatitis Genomics Infrared Rays Clear Cell Adenocarcinoma Non-muscle-invasive Mutation Propensity Score Immune checkpoint inhibitor Angiogenesis Inhibitors Cyclooxygenase 2 Melanoma Sunitinib Cystectomy Urothelial carcinoma Skin Neoplasms Vascular Endothelial Growth Factor A epidemiology Programmed death 1 axis inhibitor Extracellular Matrix Propensity-score neoplasm invasion Il-22 Maintenance Chemotherapy surgery Intracellular Signaling Peptides and Proteins mitochondria Atorvastatin Calcium Cisplatin Fibroblasts Carcinogenesis Homeostasis pd-1 cytokines Cell Cycle Checkpoints Breast Neoplasms Local Neoplasm Recurrence Somatic mutation Argonaute Proteins HIV-1 Immunophenotyping First-line chemotherapy Carcinoma Genetic Heterogeneity Attitudes Health Knowledge-Practice pd-l1 microRNA biogenesis Piperazines cancer prevention Animal Mammary Glands Metastatic renal cell carcinoma Pancreatic Neoplasms Hematologic Neoplasms lung cancer Tumor Biomarkers Animal Disease Models Raman spectroscopy Diet deficiency Lipid Metabolism Patient Dropouts Pazopanib Interleukins Prostatic Neoplasms Urothelium Celecoxib Autophagy DEAD-box RNA Helicases Mitogen-Activated Protein Kinases biomarker
Last updated on Wednesday, March 04, 2020